The GM2 Glycan Serves as a Functional Coreceptor for Serotype 1 Reovirus

PLoS Pathogens

Volumn 8, Issue 12, 2012, Pages

  Reiss, Kerstin ^a   Stencel, Jennifer E ^b   Liu, Yan ^c   Blaum, Bärbel S ^a   Reiter, Dirk M ^a   Feizi, Ten ^c   Dermody, Terence S ^b   Stehle, Thilo ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM2; N ACETYLGALACTOSAMINE; N ACETYLNEURAMINIC ACID; REOVIRUS STRAIN TYPE 1 LANG OMEGA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REOVIRUS; REOVIRUS INFECTION; SEQUENCE ALIGNMENT; VIRUS ATTACHMENT; VIRUS HEMAGGLUTINATION; VIRUS INFECTIVITY;

ANIMALS; CRICETINAE; EMBRYO, MAMMALIAN; FIBROBLASTS; GANGLIOSIDOSES, GM2; L CELLS (CELL LINE); MICE; MUTATION; ORTHOREOVIRUS, MAMMALIAN; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; REOVIRIDAE INFECTIONS; VIRAL PROTEINS;

MAMMALIA; ORTHOREOVIRUS;

EID: 84872012181     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003078     Document Type: Article

References (90)

1. Haywood AM, (1994) Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol 68: 1-5.
2. Dermody TS, Parker J, Sherry B (2012) Orthoreovirus. In: D.M. K, P.M. H, editors. Fields Virology. 6th edition. Philadelphia: Lippincott Williams & Wilkins.
3. Tai JH, Williams JV, Edwards KM, Wright PF, Crowe JE Jr, et al. (2005) Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J Infect Dis 191: 1221-1224.
4. Coffey MC, Strong JE, Forsyth PA, Lee PW, (1998) Reovirus therapy of tumors with activated Ras pathway. Science 282: 1332-1334.
5. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW, (1998) The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 17: 3351-3362.
6. Adair RA, Roulstone V, Scott KJ, Morgan R, Nuovo GJ, et al. (2012) Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci Transl Med 4: 138ra177.
7. Tyler KL, McPhee DA, Fields BN, (1986) Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 233: 770-774.
8. Weiner HL, Drayna D, Averill DR Jr, Fields BN, (1977) Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A 74: 5744-5748.
9. Weiner HL, Powers ML, Fields BN, (1980) Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis 141: 609-616.
10. Morrison LA, Sidman RL, Fields BN, (1991) Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A 88: 3852-3856.
11. Antar AA, Konopka JL, Campbell JA, Henry RA, Perdigoto AL, et al. (2009) Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe 5: 59-71.
12. Boehme KW, Frierson JM, Konopka JL, Kobayashi T, Dermody TS, (2011) The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice. J Virol 85: 11781-11790.
13. Lee PW, Hayes EC, Joklik WK, (1981) Protein sigma 1 is the reovirus cell attachment protein. Virology 108: 156-163.
14. Furlong DB, Nibert ML, Fields BN, (1988) Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol 62: 246-256.
15. Nibert ML, Dermody TS, Fields BN, (1990) Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol 64: 2976-2989.
16. Lupas A, Van Dyke M, Stock J, (1991) Predicting coiled coils from protein sequences. Science 252: 1162-1164.
17. Duncan R, Horne D, Cashdollar LW, Joklik WK, Lee PW, (1990) Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus. Virology 174: 399-409.
18. Chappell JD, Prota AE, Dermody TS, Stehle T, (2002) Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber. EMBO J 21: 1-11.
19. Reiter DM, Frierson JM, Halvorson EE, Kobayashi T, Dermody TS, et al. (2011) Crystal structure of reovirus attachment protein sigma1 in complex with sialylated oligosaccharides. PLoS Pathog 7: e1002166.
20. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. (2001) Junction adhesion molecule is a receptor for reovirus. Cell 104: 441-451.
21. Campbell JA, Schelling P, Wetzel JD, Johnson EM, Forrest JC, et al. (2005) Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 79: 7967-7978.
22. Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, et al. (2003) Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A 100: 5366-5371.
23. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, et al. (2000) Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113 (Pt 13): 2363-2374.
24. Schelling P, Guglielmi KM, Kirchner E, Paetzold B, Dermody TS, et al. (2007) The reovirus sigma1 aspartic acid sandwich: a trimerization motif poised for conformational change. J Biol Chem 282: 11582-11589.
25. Kirchner E, Guglielmi KM, Strauss HM, Dermody TS, Stehle T, (2008) Structure of reovirus sigma1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog 4: e1000235.
26. Kirchner E (2009) Structural and functional studies of the reovirus attachment protein sigma1 and its interaction with the receptor JAM-A Elektronische Ressource. pp. Online-Resource.
27. Chappell JD, Duong JL, Wright BW, Dermody TS, (2000) Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 74: 8472-8479.
28. Lerner AM, Cherry JD, Finland M, (1963) Hemagglutination with reoviruses. Virology 19: 58-65.
29. Gomatos PJ, Tamm I, (1962) Reactive sites of reovirus type 3 and their interaction with receptor substances. Virology 17: 455-461.
30. Helander A, Silvey KJ, Mantis NJ, Hutchings AB, Chandran K, et al. (2003) The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 77: 7964-7977.
31. Paul RW, Lee PW, (1987) Glycophorin is the reovirus receptor on human erythrocytes. Virology 159: 94-101.
32. Nibert ML, Chappell JD, Dermody TS, (1995) Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J Virol 69: 5057-5067.
33. Barton ES, Connolly JL, Forrest JC, Chappell JD, Dermody TS, (2001) Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 276: 2200-2211.
34. Shevchuk NA, Hathout Y, Epifano O, Su Y, Liu Y, et al. (2007) Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts. Biochim Biophys Acta 1771: 1226-1234.
35. Yogeeswaran G, Fujinami R, Kiessling R, Welsh RM, (1982) Interferon-induced alterations in sialic acid and glycoconjugates of L-929 cells. Virology 121: 363-371.
36. Mayer M, Meyer B, (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angewandte Chemie-International Edition 38: 1784-1788.
37. Meyer B, Peters T, (2003) NMR Spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angewandte Chemie-International Edition 42: 864-890.
38. Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, et al. (2012) Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog 8: e1002738.
39. van Raaij MJ, Mitraki A, Lavigne G, Cusack S, (1999) A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 401: 935-938.
40. Lutteke T, Frank M, von der Lieth CW, (2005) Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB. Nucleic Acids Res 33: D242-246.
41. Levery SB, (1991) 1H-NMR study of GM2 ganglioside: evidence that an interresidue amide-carboxyl hydrogen bond contributes to stabilization of a preferred conformation. Glycoconj J 8: 484-492.
42. Kobayashi T, Ooms LS, Ikizler M, Chappell JD, Dermody TS, (2010) An improved reverse genetics system for mammalian orthoreoviruses. Virology 398: 194-200.
43. Helander A, Miller CL, Myers KS, Neutra MR, Nibert ML, (2004) Protective immunoglobulin A and G antibodies bind to overlapping intersubunit epitopes in the head domain of type 1 reovirus adhesin sigma1. J Virol 78: 10695-10705.
44. Muchmore EA, Diaz S, Varki A, (1998) A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 107: 187-198.
45. Musielak M, (2004) Are there two functionally distinguished Neu5Gc pools with respect to rouleau formation on the bovine red blood cell? Clin Hemorheol Microcirc 30: 435-438.
46. Turnbull WB, Precious BL, Homans SW, (2004) Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J Am Chem Soc 126: 1047-1054.
47. Chen R, Jiang X, Sun D, Han G, Wang F, et al. (2009) Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 8: 651-661.
48. Guglielmi KM, Kirchner E, Holm GH, Stehle T, Dermody TS, (2007) Reovirus binding determinants in junctional adhesion molecule-A. J Biol Chem 282: 17930-17940.
49. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Dickeson SK, Santoro SA, et al. (2006) Beta1 integrin mediates internalization of mammalian reovirus. J Virol 80: 2760-2770.
50. Mikami T, Kashiwagi M, Tsuchihashi K, Daino T, Akino T, et al. (1998) Further characterization of equine brain gangliosides: the presence of GM3 having N-glycolyl neuraminic acid in the central nervous system. J Biochem 123: 487-491.
51. Rodrig N, Osanai T, Iwamori M, Nagai Y, (1988) Uncoupling of intracellular cyclic AMP and dome formation in cultured canine kidney epithelial cells: effects of gangliosides and vasopressin. J Biochem 104: 215-219.
52. Cochran FB Jr, Yu RK, Ledeen RW, (1982) Myelin gangliosides in vertebrates. J Neurochem 39: 773-779.
53. Phillips PA, Alpers MP, Stanley NF, (1970) Hydrocephalus in mice inoculated neonatally by the oronasal route with reovirus type 1. Science 168: 858-859.
54. Barton ES, Youree BE, Ebert DH, Forrest JC, Connolly JL, et al. (2003) Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest 111: 1823-1833.
55. Frierson JM, Pruijssers AJ, Konopka JL, Reiter DM, Abel TW, et al. (2012) Utilization of Sialylated Glycans as Coreceptors Enhances the Neurovirulence of Serotype 3 Reovirus. J Virol in press.
56. Raval G, Biswas S, Rayman P, Biswas K, Sa G, et al. (2007) TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction. J Immunol 178: 6642-6652.
57. Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, et al. (1982) Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 156: 1884-1889.
58. Cahan LD, Irie RF, Singh R, Cassidenti A, Paulson JC, (1982) Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A 79: 7629-7633.
59. Yamada T, Bando H, Takeuchi S, Kita K, Li Q, et al. (2011) Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells. Cancer Sci 102: 2157-2163.
60. Harbury PB, Zhang T, Kim PS, Alber T, (1993) A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 262: 1401-1407.
61. Harbury PB, Kim PS, Alber T, (1994) Crystal structure of an isoleucine-zipper trimer. Nature 371: 80-83.
62. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, et al. (2006) Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 281: 5771-5779.
63. Palma AS, Zhang Y, Childs RA, Campanero-Rhodes MA, Liu Y, et al. (2012) Neoglycolipid-based "designer" oligosaccharide microarrays to define beta-glucan ligands for Dectin-1. Methods Mol Biol 808: 337-359.
64. Stoll M, Feizi T. Software Tools for Storing, Processing and Displaying Carbohydrate Microarray Data. In: Kettner C, editor. 4-8 October, 2009. Potsdam, Germany. Frankfurt, Germany: Beilstein Institute for the Advancement of Chemical Sciences. pp. 123-140.
65. Kabsch W, (2010) Xds. Acta Crystallogr D Biol Crystallogr 66: 125-132.
66. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760-763.
67. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
68. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
69. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
70. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58: 1948-1954.
71. Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, et al. (2011) BUSTER version 2.10.0.
72. Smart OS, Womack TO, Flensburg C, Keller P, Paciorek W, et al. (2012) Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr D Biol Crystallogr 68: 368-380.
73. DeLano WL (2010) The PyMOL Molecular Graphics System. Version 1.2r3pre. Schrödinger, LLC.
74. Notredame C, Higgins DG, Heringa J, (2000) T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205-217.
75. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
76. Clamp M, Cuff J, Searle SM, Barton GJ, (2004) The Jalview Java alignment editor. Bioinformatics 20: 426-427.
77. Krissinel E, Henrick K, (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60: 2256-2268.
78. Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, et al. (2003) Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50: 437-450.
79. Lee B, Richards FM, (1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379-400.
80. Saff EB, Kuijlaars ABJ, (1997) Distributing many points on a sphere. Mathematical Intelligencer 19: 5-11.
81. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, et al. (1995) 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6: 135-140.
82. Danthi P, Pruijssers AJ, Berger AK, Holm GH, Zinkel SS, et al. (2010) Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog 6: e1000980.
83. Kobayashi T, Antar AA, Boehme KW, Danthi P, Eby EA, et al. (2007) A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1: 147-157.
84. Virgin HWt, Bassel-Duby R, Fields BN, Tyler KL, (1988) Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol 62: 4594-4604.
85. Smith RE, Zweerink HJ, Joklik WK, (1969) Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39: 791-810.
86. Wilson GJ, Wetzel JD, Puryear W, Bassel-Duby R, Dermody TS, (1996) Persistent reovirus infections of L cells select mutations in viral attachment protein sigma1 that alter oligomer stability. J Virol 70: 6598-6606.
87. Wetzel JD, Chappell JD, Fogo AB, Dermody TS, (1997) Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J Virol 71: 299-306.
88. Virgin HWt, Mann MA, Fields BN, Tyler KL, (1991) Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol 65: 6772-6781.
89. Iskarpatyoti JA, Willis JZ, Guan J, Ashley Morse E, Ikizler M, et al. (2012) A rapid, automated approach for quantitation of rotavirus and reovirus infectivity. J Virol Methods 184: 1-7.
90. Karplus PA, Diederichs K, (2012) Linking crystallographic model and data quality. Science 336: 1030-1033.